Shu Qin Wei1,2, Marianne Bilodeau-Bertrand2, Nathalie Auger2,3,4. 1. Department of Obstetrics and Gynecology, Sainte-Justine Hospital Research Center, University of Montreal, Montreal, Canada. 2. Bureau d'information et d'études en santé des populations, Institut national de santé publique du Québec, Montreal, Canada. 3. Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada. 4. Department of Social and Preventive Medicine, School of Public Health, University of Montreal Hospital Research Centre, University of Montreal, Montreal, Canada.
Abstract
STUDY QUESTION: Do children whose mothers have polycystic ovary syndrome (PCOS) have an increased risk of morbidity? SUMMARY ANSWER: Maternal PCOS is associated with an increased risk of infection, allergy and other childhood morbidity. WHAT IS KNOWN ALREADY: PCOS is associated with higher rates of gestational diabetes, pre-eclampsia and preterm delivery, but the long-term impact on child health is poorly understood. STUDY DESIGN, SIZE, DURATION: We conducted a retrospective longitudinal cohort study of 1 038 375 children in Quebec between 2006 and 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: We included 7160 children whose mothers had PCOS and 1 031 215 unexposed children. Outcomes included child hospitalization for infectious, allergic, malignant and other diseases before 13 years of age. We estimated hazard ratios (HRs) and 95% CI for the association of PCOS with childhood morbidity in adjusted Cox proportional hazards regression models. MAIN RESULTS AND THE ROLE OF CHANCE: Children exposed to PCOS were hospitalized at a rate of 68.9 (95% CI 66.2-71.8) per 1000 person-years, whereas unexposed children were hospitalized at a rate of 45.3 (95% CI 45.1-45.5) per 1000 person-years. Compared with no exposure, maternal PCOS was associated with 1.32 times the risk of any childhood hospitalization (95% CI 1.26-1.40), 1.31 times the risk of infectious disease hospitalization (95% CI 1.25-1.38) and 1.47 times the risk of allergy-related hospitalization (95% CI 1.31-1.66). Risk of hospitalization was also elevated for childhood metabolic (HR 1.59, 95% CI 1.16-2.18), gastrointestinal (HR 1.72, 95% CI 1.53-1.92), central nervous system (HR 1.74, 95% CI 1.46-2.07) and otologic disorders (HR 1.34, 95% CI 1.26-1.43). Subgroup analyses suggested that there was little difference in the association of PCOS with hospitalization among boys (HR 1.31, 95% CI 1.24-1.39) and girls (HR 1.34, 95% CI 1.26-1.43). LIMITATIONS, REASONS FOR CAUTION: We analyzed severe childhood morbidity requiring hospitalization, not mild diseases treated in ambulatory clinics. We lacked data on ethnicity, education and physical activity, and cannot rule out residual confounding. WIDER IMPLICATIONS OF THE FINDINGS: Our findings suggest that maternal PCOS is associated with an increased risk of childhood morbidity. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by grant PJT-162300 from the Canadian Institutes of Health Research. N.A. acknowledges a career award from the Fonds de recherche du Québec-Santé (296785). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.
STUDY QUESTION: Do children whose mothers have polycystic ovary syndrome (PCOS) have an increased risk of morbidity? SUMMARY ANSWER: Maternal PCOS is associated with an increased risk of infection, allergy and other childhood morbidity. WHAT IS KNOWN ALREADY: PCOS is associated with higher rates of gestational diabetes, pre-eclampsia and preterm delivery, but the long-term impact on child health is poorly understood. STUDY DESIGN, SIZE, DURATION: We conducted a retrospective longitudinal cohort study of 1 038 375 children in Quebec between 2006 and 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: We included 7160 children whose mothers had PCOS and 1 031 215 unexposed children. Outcomes included child hospitalization for infectious, allergic, malignant and other diseases before 13 years of age. We estimated hazard ratios (HRs) and 95% CI for the association of PCOS with childhood morbidity in adjusted Cox proportional hazards regression models. MAIN RESULTS AND THE ROLE OF CHANCE: Children exposed to PCOS were hospitalized at a rate of 68.9 (95% CI 66.2-71.8) per 1000 person-years, whereas unexposed children were hospitalized at a rate of 45.3 (95% CI 45.1-45.5) per 1000 person-years. Compared with no exposure, maternal PCOS was associated with 1.32 times the risk of any childhood hospitalization (95% CI 1.26-1.40), 1.31 times the risk of infectious disease hospitalization (95% CI 1.25-1.38) and 1.47 times the risk of allergy-related hospitalization (95% CI 1.31-1.66). Risk of hospitalization was also elevated for childhood metabolic (HR 1.59, 95% CI 1.16-2.18), gastrointestinal (HR 1.72, 95% CI 1.53-1.92), central nervous system (HR 1.74, 95% CI 1.46-2.07) and otologic disorders (HR 1.34, 95% CI 1.26-1.43). Subgroup analyses suggested that there was little difference in the association of PCOS with hospitalization among boys (HR 1.31, 95% CI 1.24-1.39) and girls (HR 1.34, 95% CI 1.26-1.43). LIMITATIONS, REASONS FOR CAUTION: We analyzed severe childhood morbidity requiring hospitalization, not mild diseases treated in ambulatory clinics. We lacked data on ethnicity, education and physical activity, and cannot rule out residual confounding. WIDER IMPLICATIONS OF THE FINDINGS: Our findings suggest that maternal PCOS is associated with an increased risk of childhood morbidity. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by grant PJT-162300 from the Canadian Institutes of Health Research. N.A. acknowledges a career award from the Fonds de recherche du Québec-Santé (296785). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.
Authors: Sara K Finnbogadóttir; Dorte Glintborg; Tina K Jensen; Henriette B Kyhl; Ellen A Nohr; Marianne Andersen Journal: Acta Obstet Gynecol Scand Date: 2017-09-20 Impact factor: 3.636
Authors: Kyriaki Kosidou; Christina Dalman; Linnea Widman; Stefan Arver; Brian K Lee; Cecilia Magnusson; Renee M Gardner Journal: Biol Psychiatry Date: 2016-10-06 Impact factor: 13.382
Authors: Stefano Palomba; Marlieke A de Wilde; Angela Falbo; Maria P H Koster; Giovanni Battista La Sala; Bart C J M Fauser Journal: Hum Reprod Update Date: 2015-06-27 Impact factor: 15.610
Authors: Nadine M P Daan; Maria P H Koster; Marlieke A de Wilde; Gerdien W Dalmeijer; Annemieke M V Evelein; Bart C J M Fauser; Wilco de Jager Journal: PLoS One Date: 2016-11-02 Impact factor: 3.240
Authors: Carolyn E Cesta; Anna S Öberg; Abraham Ibrahimson; Ikram Yusuf; Henrik Larsson; Catarina Almqvist; Brian M D'Onofrio; Cynthia M Bulik; Lorena Fernández de la Cruz; David Mataix-Cols; Mikael Landén; Mina A Rosenqvist Journal: Psychol Med Date: 2019-03-12 Impact factor: 7.723
Authors: Sanjiv Risal; Yu Pei; Haojiang Lu; Maria Manti; Romina Fornes; Han-Pin Pui; Zhiyi Zhao; Julie Massart; Claes Ohlsson; Eva Lindgren; Nicolas Crisosto; Manuel Maliqueo; Barbara Echiburú; Amanda Ladrón de Guevara; Teresa Sir-Petermann; Henrik Larsson; Mina A Rosenqvist; Carolyn E Cesta; Anna Benrick; Qiaolin Deng; Elisabet Stener-Victorin Journal: Nat Med Date: 2019-12-02 Impact factor: 53.440
Authors: Marlise N Gunning; Teresa Sir Petermann; Nicolas Crisosto; Bas B van Rijn; Marlieke A de Wilde; Jacob P Christ; C S P M Uiterwaal; Wilco de Jager; Marinus J C Eijkemans; Allen R Kunselman; Richard S Legro; Bart C J M Fauser Journal: Hum Reprod Update Date: 2020-01-01 Impact factor: 15.610